Probing cathepsin K activity with a selective substrate spanning its active site.
暂无分享,去创建一个
[1] K. Abromeit. Music Received , 2022, Notes.
[2] R. Thomas,et al. Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] D. Turk,et al. Lysosomal cysteine proteases (cathepsins): promising drug targets. , 2003, Acta crystallographica. Section D, Biological crystallography.
[4] D. Brömme,et al. Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. , 2002, Chemical reviews.
[5] T. Welte,et al. Expression of cathepsins B, H, K, L, and S during human fetal lung development , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.
[6] B. Gelb,et al. Collagenase Activity of Cathepsin K Depends on Complex Formation with Chondroitin Sulfate* , 2002, The Journal of Biological Chemistry.
[7] C. Craik,et al. Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity. , 2002, Biochemistry.
[8] T. Welte,et al. Cathepsin K – a marker of macrophage differentiation? , 2001, The Journal of pathology.
[9] Y. Ru,et al. Potent and Selective Inhibition of Human Cathepsin K Leads to Inhibition of Bone Resorption In Vivo in a Nonhuman Primate , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] T. Moreau,et al. Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids. , 2001, European journal of biochemistry.
[11] E. Young,et al. Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K. , 2000, Blood.
[12] L. Juliano,et al. Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates. , 2000, The Biochemical journal.
[13] D. Brömme,et al. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. , 2000, Biochemistry.
[14] J. Palmer,et al. Localization of Rat Cathepsin K in Osteoclasts and Resorption Pits: Inhibition of Bone Resorption and Cathepsin K-Activity by Peptidyl Vinyl Sulfones , 1999, Biological chemistry.
[15] E. Mehler,et al. Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. , 1999, Biochemistry.
[16] P. Delmas,et al. The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases* , 1998, The Journal of Biological Chemistry.
[17] H. Chapman,et al. Human Cathepsin F , 1998, The Journal of Biological Chemistry.
[18] Sheila J. Jones,et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] V. Duance,et al. Effects of transforming growth factor‐beta 1 on the assembly of matrix by bovine fibroblasts grown in a 3‐dimensional matrix , 1998 .
[20] J G Gleason,et al. Design of potent and selective human cathepsin K inhibitors that span the active site. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Juliano,et al. A comparison of the enzymatic properties of the major cysteine proteinases from Trypanosoma congolense and Trypanosoma cruzi. , 1997, Molecular and biochemical parasitology.
[22] D. Turk,et al. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. , 1997, Biological chemistry.
[23] J. Scharfstein,et al. Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors. , 1996, The Biochemical journal.
[24] R. Ménard,et al. The specificity of the S1' subsite of cysteine proteases , 1993, FEBS letters.
[25] P. Webster,et al. Identification of a 33-kilodalton immunodominant antigen of Trypanosoma congolense as a cysteine protease. , 1992, Molecular and biochemical parasitology.
[26] T. Moreau,et al. Photometric or fluorometric assay of cathepsin B, L and H and papain using substrates with an aminotrifluoromethylcoumarin leaving group. , 1991, Biochimica et biophysica acta.
[27] C. Craik,et al. Introduction of a cysteine protease active site into trypsin. , 1989, Biochemistry.
[28] A. Lanzavecchia,et al. Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes. , 1988, Journal of immunology.
[29] T. Moreau,et al. Cysteine-proteinase-inhibiting function of T kininogen and of its proteolytic fragments. , 1988, European journal of biochemistry.
[30] H. Kirschke,et al. Enzyme-substrate interactions in the hydrolysis of peptides by cathepsins B and H from rat liver. , 1987, The Biochemical journal.
[31] D. Yamashita,et al. Cathepsin K and the design of inhibitors of cathepsin K. , 2000, Current pharmaceutical design.
[32] J. Scharfstein,et al. Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases. , 1999, European journal of biochemistry.
[33] A. Barrett,et al. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. , 1982, The Biochemical journal.